Detalles de la búsqueda
1.
Evaluation of the efficacy of pimavanserin in the treatment of agitation and aggression in patients with Alzheimer's disease psychosis: A post hoc analysis.
Int J Geriatr Psychiatry
; 35(11): 1402-1408, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32729631
2.
Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.
Mov Disord
; 33(11): 1769-1776, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30387904
3.
Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trial.
HIV Clin Trials
; 17(2): 72-7, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26917112
4.
Risk factors predictive of anemia development during telaprevir plus peginterferon/ribavirin therapy in treatment-experienced patients.
J Hepatol
; 60(6): 1112-7, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24486089
5.
Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial.
Hepatology
; 58(6): 1897-906, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24382638
6.
The effects of treatment with pimavanserin on activities of daily living in patients with Parkinson's disease psychosis: a 16-week, single-arm, open-label study.
Ther Adv Neurol Disord
; 17: 17562864241228350, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38476466
7.
Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study.
J Alzheimers Dis
; 98(1): 265-274, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38427485
8.
Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis.
Front Neurol
; 13: 919778, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36277907
9.
Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients.
Parkinsonism Relat Disord
; 87: 25-31, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33933853
10.
Blinded SAPS-PD Assessment After 10 Weeks of Pimavanserin Treatment for Parkinson's Disease Psychosis.
J Parkinsons Dis
; 10(4): 1389-1396, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32716320
11.
An Open-Label, 8-Week Study of Safety and Efficacy of Pimavanserin Treatment in Adults with Parkinson's Disease and Depression.
J Parkinsons Dis
; 10(4): 1751-1761, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32804101
12.
Nighttime Sleep and Daytime Sleepiness Improved With Pimavanserin During Treatment of Parkinson's Disease Psychosis.
Clin Neuropharmacol
; 41(6): 210-215, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30303817
13.
Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study.
Lancet Neurol
; 17(3): 213-222, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29452684
14.
Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.
J Am Med Dir Assoc
; 16(10): 898.e1-7, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26239690
15.
Outcomes in older versus younger patients over 96 weeks in HIV-1- infected patients treated with rilpivirine or efavirenz in ECHO and THRIVE.
Curr HIV Res
; 11(7): 570-5, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24467642
16.
Week 96 outcomes of patients with less treatment experience versus more treatment experience receiving etravirine in the DUET trials.
Curr HIV Res
; 10(3): 256-61, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22497697
17.
Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1-Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial.
AIDS Res Treat
; 2012: 186987, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22536495
18.
Health-related quality of life in the gender, race, and clinical experience trial.
AIDS Res Treat
; 2011: 349165, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21904672
19.
Homeostasis Model Assessment of Insulin Resistance Does Not Seem to Predict Response to Telaprevir in Chronic Hepatitis C in the REALIZE Trial
Hepatology (Baltim.)
; 58(6): 1897-1906, Dec. 2013.
Artículo
en Inglés
| SES-SP, SESSP-IIERPROD, SES-SP | ID: biblio-1063281
Resultados
1 -
19
de 19
1
Próxima >
>>